Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice
被引:101
作者:
Aumeunier, Aude
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Aumeunier, Aude
[1
,2
]
Grela, Francoise
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Grela, Francoise
[1
,2
]
Ramadan, Abdulraouf
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Ramadan, Abdulraouf
[1
,2
]
Linh Pham Van
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Linh Pham Van
[1
,2
]
Bardel, Emilie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Bardel, Emilie
[1
,2
]
Alcala, Alejandro Gomez
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Alcala, Alejandro Gomez
[1
,2
]
Jeannin, Pascale
论文数: 0引用数: 0
h-index: 0
机构:
INSERM, U564, Angers, FranceUniv Paris 05, Paris, France
Jeannin, Pascale
[3
]
Akira, Shizuo
论文数: 0引用数: 0
h-index: 0
机构:
Osaka Univ, Dept Host Def, Osaka, JapanUniv Paris 05, Paris, France
Akira, Shizuo
[4
]
Bach, Jean-Francois
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
INSERM, U1013, Paris, FranceUniv Paris 05, Paris, France
Bach, Jean-Francois
[1
,5
]
Thieblemont, Nathalie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Paris 05, Paris, France
CNRS, UMR8147, Paris, FranceUniv Paris 05, Paris, France
Thieblemont, Nathalie
[1
,2
]
机构:
[1] Univ Paris 05, Paris, France
[2] CNRS, UMR8147, Paris, France
[3] INSERM, U564, Angers, France
[4] Osaka Univ, Dept Host Def, Osaka, Japan
[5] INSERM, U1013, Paris, France
来源:
PLOS ONE
|
2010年
/
5卷
/
07期
关键词:
D O I:
10.1371/journal.pone.0011484
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Background: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity. Methods and Findings: Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-beta and different subsets of regulatory T cells, notably CD4(+)CD25(+)FoxP3(+) T cells for TLR4 agonists and NKT cells for TLR3 agonists. Conclusions/Significance: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies.